Body mass index has long been treated as the single most powerful lever over a child’s blood pressure, a relationship so consistent that pediatric guidelines around the world implicitly assume it applies equally to every child. A new study published in Pediatric Research challenges that assumption with a finding that is as subtle as it is consequential: the strength of the BMI–blood pressure link depends on what happened in the womb. Researchers led by Aneta Sitek of the University of Lodz report that pregnancy complications and a child’s sex both modify how strongly body mass translates into elevated blood pressure, adding a developmental layer to one of medicine’s most familiar risk equations.
The study, a cross-sectional analysis of 769 children aged six to thirteen years, excluded any child with a chronic condition known to affect blood pressure. Systolic and diastolic pressures were measured with a standardized protocol, and prenatal and family information came from questionnaires completed by parents. The team then built hierarchical linear regression models, adjusting for age, sex, height, BMI, birth weight expressed as a z-score, and socioeconomic factors. Crucially, they added interaction terms to the models, statistical devices that test whether the effect of one variable changes depending on the level of another. It was these interaction terms that revealed the hidden structure in the data.
The headline result is straightforward: BMI was the strongest predictor of both systolic and diastolic blood pressure in the sample, confirming its status as the dominant modifiable determinant of childhood blood pressure. But among the prenatal variables the researchers examined, only one carried an independent signal. Children whose mothers had experienced pregnancy complications showed systolic blood pressure roughly 2.5 mmHg higher than peers whose pregnancies had been uncomplicated. Other prenatal factors, including birth weight itself, did not show significant independent associations once the full set of covariates was accounted for, a result that will surprise readers raised on the classic fetal origins literature.
That surprise is precisely where the study becomes interesting. The Barker hypothesis, articulated in 1995, proposed that coronary heart disease in adulthood is rooted in fetal undernutrition, and dozens of studies since have reported inverse associations between birth weight and later blood pressure. The Lodz team’s data did not reproduce a significant direct birth-weight effect in these children, but they found something arguably more informative: a statistically significant interaction between BMI and pregnancy complications for both systolic and diastolic pressure. The BMI–blood pressure association was stronger in children from uncomplicated pregnancies than in those whose mothers had experienced prenatal complications.
Interpreting an interaction of this kind requires care, and the authors frame it within the Developmental Origins of Health and Disease, or DOHaD, framework. That paradigm holds that conditions encountered in utero can permanently tune physiological systems, a process often described as developmental programming. Mechanistically, several pathways could connect a complicated pregnancy to altered cardiovascular regulation. Adverse intrauterine environments are associated with reduced nephron number, the so-called oligonephropathy hypothesis, which forces remaining kidney filtration units to work harder and predisposes the individual to hypertension. Complicated pregnancies, particularly those involving preeclampsia or growth restriction, are also linked to impaired endothelial function and increased arterial stiffness in offspring, effects documented in children as young as nine years old.
If prenatal adversity already pushes blood pressure upward through these fixed mechanisms, the additional contribution of excess body mass may be partially masked or saturated, which is one plausible reading of the attenuated BMI effect among children exposed to complications. In other words, when the developmental baseline is already shifted, the incremental pressure exerted by adiposity may be less visible in the statistical model. Conversely, children from uncomplicated pregnancies may have more headroom for the obesity-related pathways, including sympathetic nervous system activation, insulin resistance, and renal sodium retention, to express themselves fully. The study does not test these mechanisms directly, and the authors are appropriately cautious, but the pattern is consistent with the idea that prenatal conditions shape individual susceptibility to obesity-related blood pressure increases.
The second interaction the team detected concerns sex. For systolic blood pressure, the BMI–pressure association was stronger in girls than in boys. Sex differences in blood pressure development are well documented, with boys typically showing higher absolute pressures from adolescence onward, driven partly by hormonal and hemodynamic differences. But a stronger coupling between adiposity and systolic pressure in preadolescent girls is a less commonly reported pattern, and it matters for risk stratification. It suggests that a given degree of excess weight may carry a different cardiovascular signal depending on the child’s sex, and that screening approaches calibrated on mixed-sex averages may misclassify children at both ends of the susceptibility spectrum.
The clinical implications follow directly from these interaction effects. Pediatric hypertension guidelines, including those from the American Academy of Pediatrics and the European Society of Hypertension, emphasize weight status as the central modifiable target, and for good reason: blood pressure tracks from childhood into adulthood, a phenomenon demonstrated most famously by the Bogalusa Heart Study, which showed that elevated readings in childhood predict adult hypertension decades later. If, however, the same BMI carries different risk depending on pregnancy history and sex, then early prevention strategies could become more precise. A child with a history of prenatal complications might warrant closer blood pressure surveillance at a lower threshold of weight gain, while the absence of such complications does not confer protection but rather a different dose–response curve.
The study’s design imposes limits that the authors acknowledge. It is cross-sectional, capturing blood pressure and body composition at a single point in time, so it cannot establish that prenatal complications causally modify the developmental trajectory of the BMI–pressure relationship; it can only show that the association differs across exposure groups. Prenatal data were retrospective, drawn from parent-completed questionnaires, which introduces the possibility of recall error, and the composite category of pregnancy complications aggregates heterogeneous conditions, from hypertensive disorders to gestational diabetes, that may act through distinct mechanisms. Blood pressure was measured on a single occasion rather than through ambulatory monitoring, which cannot capture nocturnal patterns known to be especially informative in obese children. The sample of 769 children from the Lodz region of Poland is well characterized but may not generalize to populations with different ancestry, socioeconomic profiles, or obstetric care.
Even with those caveats, the findings earn their place in a shifting scientific conversation. Genetic studies have identified hundreds of loci associated with blood pressure traits, yet the environment in which those genes are expressed begins before birth, and epigenetic modifications laid down in utero can persist for decades. By demonstrating that interaction effects, not just main effects, are detectable in childhood, the Lodz team extends the DOHaD framework into a domain where intervention is still possible. The 2.5 mmHg systolic increment associated with pregnancy complications is modest at the individual level, but across a population it is the kind of shift that changes the distribution of cardiovascular risk. And the demonstration that BMI is not a uniform predictor, but one whose potency is conditioned by prenatal history and sex, argues for a pediatric cardiology that reads two histories at once: the child’s and the pregnancy’s. For a field accustomed to treating childhood blood pressure as a simple function of current body size, that is a genuinely reframing result.
Subject of Research: Modification of the childhood BMI–blood pressure relationship by prenatal complications and sex
Article Title: Prenatal complications and sex modify the BMI–blood pressure relationship in children
Article References: Sitek, A., Pruszkowska-Przybylska, P., Rosset, I., Kurek, M., Mietlińska-Sauter, J., Kobus, M., Karkus, J., Sękowski, P., & Żądzińska, E. (2026). Prenatal complications and sex modify the BMI–blood pressure relationship in children. Pediatric Research. https://doi.org/10.1038/s41390-026-05528-w
Image Credits: AI Generated
DOI: 10.1038/s41390-026-05528-w
Keywords: blood pressure, body mass index, children, pregnancy complications, developmental origins of health and disease, pediatric hypertension, DOHaD, fetal programming, sex differences, cardiovascular risk, epidemiology, Pediatric Research
Cite Scienmag News
Harold Sullivan. (September 24, 2026). Pregnancy Complications and Sex Reshape How Body Weight Drives Childhood Blood Pressure. Scienmag. https://scienmag.com/pregnancy-complications-and-sex-reshape-how-body-weight-drives-childhood-blood-pressure/
Harold Sullivan. "Pregnancy Complications and Sex Reshape How Body Weight Drives Childhood Blood Pressure." Scienmag, 24 September 2026, https://scienmag.com/pregnancy-complications-and-sex-reshape-how-body-weight-drives-childhood-blood-pressure/. Accessed 24 September 2026.
Harold Sullivan. "Pregnancy Complications and Sex Reshape How Body Weight Drives Childhood Blood Pressure." Scienmag. September 24, 2026. https://scienmag.com/pregnancy-complications-and-sex-reshape-how-body-weight-drives-childhood-blood-pressure/

